current numbers
list of articles:
 |
|
||
|
kwartalnik ISSN 0500-7208 Czasopismo punktowane przez KBN, Index Copernicus oraz w bazie GBL |
CLINICAL AND ANTIBACTERIAL EFFECTIVENESS OF AZTREONAM IN INFECTIONS RESISTANT TO OTHER ANTIBIOTICS
Article published in Urologia Polska 1990/43/4.
authors
- Władysław Tkaczewski, Zbigniew Pieloch, Eugeniusz Miękoś, Czesław Pawlak, Halina Adamska-Dyniewska, Andrzej Szymanski, Anna Bara
- Z III Kliniki Chorób Wewnętrznych IMW Kierownik: prof. dr hab. med. W. Tkaczewski
Z Kliniki Urologii ICH
Kierownik: prof. dr hab. med. E. Miękoś
Z Zakładu Farmakologii Klinicznej IMW
Kierownik: prof. dr hab. med. H. Adamska-Dyniewska
Z Klinika Pneumonologicznej IMW
Kierownik: prof. dr hab. med. A. Szymański
Wojskowej Akademii Medycznej w Łodzi
summary
- The semsitivity of bacteria to aztreonam was assessed in vitro and the ef-fedtaveines/s of the drug was analysed in the treatment of severe infections of urogenital infections and lower airways infections in 21 patients. The study of bacterial sensitivity was carried out on the basis of 588 cultures from 621 samples of biological material. It was found that in vitro aztreonam activity against Gram-negative bacteria was high and was found in 83.0% of strains. The clinical effectiveness of the antibiotic was also high: very good clinical effect was noted in 57.2%, good in 23,8%, and in 81.0°/o of all treated cases.
references
- 1. Buesing M., Jorgensen J,: In vitro activity of aztreonam In Combination with nevar beta-lactaims and amikacin against multiply resistant gram negałdve bacilli. Anitimierob. Agentts Chemother., 1:984, 25, 283. ? 2. Childs S.: Aztreonam in the treatment of urinary tract infection.. Am. J. Med. 1965, 78 (Suppl. 2A), 44. ? 3. Cox C: Aztreonam therapy of complicated urinary tract infoctioinjs due to multirirug-resistant bacteria. Chemotherapy, 19fii3, 4 (Suppl. 1), 46. ? 4. Feris J'., Moledzna N., Rodriguez W., Khan W., Puig J., Wiederman B,, Ahmad S.: Az.tre-onam in the treatment of gram-negatave meningitis and other graimnegaitiive 5n-fecticuŁs. Chemotherapy, 1989, 35 (Suppl. 1), 49. ? 6. Georgopapadalcou N., Smith S., Sykes R.: Modę of action of Aztreonam. Antimicrob. Agents Chemother., 1S82, 21, 950. ? 6. Marco V. Gobernado M., Santos M,, Rabinad E.: Comparattive study of Aztreonam in Gram-negative paeumoma versus a thera;peutic regimen thait tocludos an aminoglycoaide. Chemotherapy, 1989, a5, (Suppl. 1). Sil. ? 7. Rabinad E., Bosch Perez A.: A multicenter oompaa:ative trial of aiz.fcreonani in the /treatment of Gram-negative infections in compromised ;intonsive-oare patients. Chemotherapy, 1989, 35 (Suppl. 1) 89. ? 8. Rehm S,, Alanis A., Hall G? Weinstein A.: Sy-necgiism between aztreonam and tobramycin, moxalactam, and piperacdllin against Pseudomonas aeruginoisa and Serratia marcescenis. 13th Initernational Congress of Chomotherapy, Proceedings. Vienna 19^83, Part 27. ? 9. Tanaka S., Banner D., Sy-kes R.: In vitro aotiv.itj' of Eztreo-natn in Combination with aminoglycosides and cther betalactams against grani posMiive and gram negaitiive bacteria. 13Ul International Congress of Chemotherapy, Proceedings. Vienna 19?3, Part 27.